XTend Medical (XMDC) Expands Product Lines to Target Billion Dollar Diabetes Nutrition Sector

SUN VALLEY, Calif., May 19 /PRNewswire-FirstCall/ — XTend Medical Corporation (Pink Sheets: XMDC) announced today the company will be adding a complete line of nutritional products aimed at capturing a portion of the Billion Dollar Medical Nutrition Sector.
The company, working in close partnership with several major manufacturers, will offer a complete line of nutritional products for patients suffering from complications and/or circumstances that prevent them from achieving proper nutrition levels to improve their daily care in managing their diabetes.
“As the company continues to move forward in delivering our Remote Patient Monitoring System, we felt it was a strong move for the company to expand our product lines to include nutritional products that will allow the company to increase sales within the diabetes sector we’re targeting. As we work with individual doctors, healthcare organizations, and clinics throughout the U.S., the ability for the company to offer the best in nutritional supplements will allow us to expand our sales opportunities to fill patient needs to properly maintain their health requirement guidelines established by their provider. The company will be selling the products through our sales staff directly to providers as well as through our online store that will be launched in the month of June. We feel that by adding nutrition products to our mix, we can continue to gain sales and assist the company in opening up additional revenue streams within our business model,” stated Mr. Paul D. Lisenby, CEO of XTend Medical.
For any healthcare agency of physician group that would like to find more about the how XTend can assist in your management of diabetic patients, please visit the company website at or email us at
About XTend Medical:
XTend Medical Corporation markets and sells healthcare and wellness products to hospitals, managed care companies, nursing homes, physician groups and individual patients. XTend has developed a complete Remote Diabetic Patient Monitoring System that is currently being used by physicians and other healthcare agencies throughout the U.S. Through their alliances, XTend offers pharmacy services, diabetic supplies, and telemedicine products that increase patient care yet reduce costs associated with servicing those patients. For more information, please visit their website at http://www.xtendmedical.com
Safe Harbor
This press release contains or may contain forward-looking statements such as statements regarding the Company’s growth and profitability, growth strategy, liquidity and access to public markets, operating expense reduction, and trends in the industry in which the Company operates. The forward-looking statements contained in this press release are also subject to other risks and uncertainties, including those more fully described in the Company’s filings with the Securities and Exchange Commission. The Company assumes no obligation to update these forward-looking statements to reflect actual results, changes in risks, uncertainties or assumptions underlying or affecting such statements, or for prospective events that may have a retroactive effect.
Contact: FutureTechIR for XTend Medical Corporation
Investor Relations
(817) 812-2105

XTend Medical Corporation